Aroa Biosurgery in trading halt for capital raise

Aroa Biosurgery in trading halt for capital raise
Aroa has five products approved for sale in the US. (Image: Supplied)
Rebecca Stevenson
New Zealand headquartered medical company Aroa will raise capital to boost its presence in the US.The Australian Financial Review reported the company was seeking A$52 million to fund the expansion of its US sales team, as well as research and development.In a June market update, the soft-tissue regeneration company said US medical procedure numbers continued to reflect a positive trend “supporting improved sales momentum”.Aroa has commercial operations based in San Diego and sales professionals across the US. In its 2021 results fo...

More Markets

NZ sharemarket up 0.4% to end the week
Markets Market close

NZ sharemarket up 0.4% to end the week

The S&P/NZX 50 Index closed at 11,794.81, up 48.15 points or 0.41%.

Graham Skellern 05 Jul 2024
Australian shares rally as dollar hits six-month high
Markets Aus Market Wrap

Australian shares rally as dollar hits six-month high

The ASX200 has risen 1.2% to hit a nine-day high.

AAP 05 Jul 2024
NZ sharemarket down, Oz and US stocks climb
Markets Market close

NZ sharemarket down, Oz and US stocks climb

The S&P/NZX 50 Index closed at 11,746.66, down 44.26 points or 0.38%.

Graham Skellern 04 Jul 2024
Summerset anticipates flat 1H underlying profit
Markets

Summerset anticipates flat 1H underlying profit

The company is NZ's best-performing retirement village operator.

Gregor Thompson 04 Jul 2024